Curran Terrie's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Aug 28, 2026
- Accession no.
- 0001628280-26-059444
- Filed
- Aug 28, 2026, 5:40 PM ET
- Trade date
- Aug 27, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $956.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Curran TerrieCIK 0001690298 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | MOption exerciseAcquired | +11,148 | $7.51 | +$83,721.48 | 34,674 | Direct | |
| Aug 27, 2026 | Common Stock | SSaleDisposed | −11,148 | $25.03 | −$279,027.75 | 23,526 | Direct | |
| Aug 27, 2026 | Common Stock | MOption exerciseAcquired | +27,052 | $8.63 | +$233,458.76 | 50,578 | Direct | |
| Aug 27, 2026 | Common Stock | SSaleDisposed | −27,052 | $25.03 | −$677,095.33 | 23,526 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | MOption exerciseDisposed | −11,148 | $0.00 | $0 | 0 | Direct | |
| Aug 27, 2026 | Common Stock | MOption exerciseDisposed | −27,052 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.